Dr. George Church is professor of Genetics at Harvard Medical School and director of Personal Genome Project. His 1984 Harvard PhD included the first methods for direct genome sequencing and molecular multiplexing, which helped initiate the Human Genome Project. In addition to innovations that contributed to nearly all next generation sequencing methods, Dr. Church is a principle inventor of protein nanopore sequencing. He has founded close to a dozen companies in the areas of Genomic Medicine, Gene Therapy and Synthetic Biology, such as Editas, Gen9, WarpDrive, Joule, Knome to name a few. Dr. Church has also pioneered new privacy, biosafety , environmental & biosecurity policies.
Dr. Chenming Hu, Professor Emeritus of EECS at UC Berkeley, is the visionary inventor of the FinFET or 3D transistor architecture. He is a world’s foremost authority on CMOS device physics, modeling and manufacturing. To address the limits of Moore’s law scaling in CMOS transistors, Dr. Hu conceived the tri-gate FinFET design that enables further scaling and integration in the third dimension by stacking-up transistors vertically. Intel began commercializing the 3D transistor based chips in 2011, with most others following soon. Dr. Hu served as Chief Technology Officer of TSMC from 2001 to 2004. He has authored four books and 900 research papers, and has been granted over 100 US patents.
Dr. Joshua LaBaer is the Director of Virginia Piper center for personalized diagnostics at the Biodesign Institute ASU, home to DNASU plasmid repository and the Sequencing Core. He is a medical oncologist, cancer researcher and nation’s leading proteomics expert. Dr. LaBaer was previously director of the Harvard Institute of Proteomics (HIP), he is founding member and serving president of US HUPO (Human Proteome Organization). He is the principal inventor of NAPPA protein microarray technologies. Dr. LaBaer is a former member of the National Cancer Institute (NCI) Board of Scientific Advisors, and currently serves as chair of NCI’s Early Detection Research Network.
JP Millon currently serves on the board of CVS Health that combines CVS Pharmacy, Caremark, Minute Clinic and CVS Specialty. He is the former President and Chief Executive Officer of PCS Health Systems Inc. He previously served on the boards of Caremark Rx and Advance PCS. Prior to that, he served in multiple leadership positions at Eli Lilly, including as President and General Manager of Lilly Japan. He has over 25 years of functional management, financial management and strategic planning experience. He serves on the boards of multiple other companies, on the CEO advisory board of a private equity firm and on the board of St Joseph Hospital Phoenix.